Dr. Allisa Song is a Korean-American entrepreneur, neuroscientist, and proponent of value-based innovation in healthcare. She received her MD from Mayo Clinic and is a published peer-reviewed author in the fields of neuroscience, ophthalmology, and plastic surgery. She is a co-founder of Nanodropper and currently serves as the CEO and Board Chair. As the visionary behind the company, she drives the core mission of bringing patient-centered solutions to improve access to vision-saving medications.
Dr. Song’s teambuilding and leadership has led to more than 20 distinctions and awards for her and her co-founders, including being recognized on Forbes 30 Under 30, Worthy 100, and the National Inventors Hall of Fame.
Dr. Song received her dual degree in Psychology Honors and Biology from the University of Washington and her research focused on the neural pathways and relationship between stress and addiction. She is a rare houseplant collector and her hobbies include dance, gardening, snowboarding, strategy board games, and hiking.
CV available upon request.
